Get the Stockscreener App
0.2399
2.32%
-0.0057
After Hours:
.26
0.0201
+8.38%
Nanovibronix Inc stock is traded at $0.2399, with a volume of 598.67K.
It is down -2.32% in the last 24 hours and down -48.52% over the past month.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.
See More
Previous Close:
$0.2456
Open:
$0.2601
24h Volume:
598.67K
Relative Volume:
0.18
Market Cap:
$2.09M
Revenue:
$3.29M
Net Income/Loss:
$-3.09M
P/E Ratio:
-0.195
EPS:
-1.23
Net Cash Flow:
$-2.46M
1W Performance:
-31.57%
1M Performance:
-48.52%
6M Performance:
-65.23%
1Y Performance:
-72.43%
1-Day Range:
$0.2007
$0.2834
1-Week Range:
$0.2007
$0.381
52-Week Range:
$0.2007
$1.27
Nanovibronix Inc Stock (NAOV) Company Profile
Name
Nanovibronix Inc
Sector
Industry
Phone
(914) 233-3004
Address
969 PRUITT AVE,, TYLER
Compare NAOV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NAOV
Nanovibronix Inc
|
0.2399 | 2.09M | 3.29M | -3.09M | -2.46M | -1.23 |
|
ABT
Abbott Laboratories
|
129.89 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.37 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.66 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.33 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
67.95 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Nanovibronix Inc Stock (NAOV) Latest News
NanoVibronix announces reverse stock split - Medical Buyer
NanoVibronix announces reverse stock split By Investing.com - Investing.com Australia
NanoVibronix Announces 1-for-11 Reverse Stock Split - Nasdaq
NanoVibronix stock hits 52-week low at $0.3 amid market challenges - Investing.com
NanoVibronix stock hits 52-week low at $0.3 amid market challenges By Investing.com - Investing.com South Africa
NanoVibronix Announces Reverse Stock Split - citybiz
Nanovibronix announces reverse stock split -March 12, 2025 at 09:44 am EDT - Marketscreener.com
NanoVibronix 1:11 Reverse Split Launches March 14Key Details for Shareholders - StockTitan
NanoVibronix shareholders approve reverse stock split By Investing.com - Investing.com South Africa
NanoVibronix shareholders approve reverse stock split - Investing.com
NanoVibronix stock plunges to 52-week low at $0.36 - Investing.com
NanoVibronix stock plunges to 52-week low at $0.36 By Investing.com - Investing.com Nigeria
NanoVibronix files to sell shares of Series G Convertible Preferred Stock, warrants - MSN
Oncolytics Biotech receives Nasdaq non-compliance notice - MSN
NanoVibronix Completes Merger with ENvue Medical Holdings - TipRanks
NanoVibronix Acquires ENvue Medical Holdings To Expand Medical Device Market Reach - Nasdaq
FDA Approves MED-EL’s Sonnet 3 Audio Processor for Cochlear Implants - MPO-mag
NanoVibronix Acquires Enteral Feeding Company ENvue - MPO-mag
NanoVibronix Acquires ENvue Medical Holdings - citybiz
NanoVibronix acquires enteral tech firm ENvue Medical - MSN
NanoVibronix Completes ENvue Medical Acquisition -February 14, 2025 at 10:54 am EST - Marketscreener.com
NanoVibronix completes acquisition of ENvue Medical - TipRanks
NanoVibronix acquires enteral tech firm ENvue Medical By Investing.com - Investing.com UK
NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp. - WICZ
Strategic Medical Tech Acquisition: NanoVibronix Takes Over Enteral Feeding Pioneer ENvue - StockTitan
Ascendis Pharma targets €200M SKYTROFA revenue and expands YORVIPATH globally in 2025 - MSN
Ocean Biomedical reports unregistered equity sales - MSN
IMUNON names Douglas Faller as chief medical officer - MSN
Pilot Phase Ends for NanoVibronix’s UroShield Study - MPO-mag
NanoVibronix Provides Year-End Business Update - ACCESS Newswire
NanoVibronix Announces Presentation of PainShield(R) to HCPCS Workgroup at CMS - ACCESS Newswire
NAOV’s 2023 Market Dance: Down -23.05% – Time to Invest? - The InvestChronicle
In the Green: MKDWELL Tech Inc (MKDW) Closes at 0.37, Up/Down -20.43 from Previous Day - The Dwinnex
Market Insights: Oncology Institute Inc (TOI)’s Notable Drop of -3.75, Closing at 0.85 - The Dwinnex
Daily Market Movement: NanoVibronix Inc (NAOV) Sees a -5.63 Decrease, Closing at 0.45 - The Dwinnex
Closing Bell Recap: FMC Corp (FMC) Ends at 35.92, Reflecting a -33.53 Downturn - The Dwinnex
EyePoint stock jumps 10% on Duravyu study results - MSN
Accuray (ARAY) Stock Surges Amidst Market Activity - GuruFocus.com
Whirlpool Corp (WHR) Shares Rise Despite Market Challenges - The News Heater
BBB Foods Inc (TBBB) Stock Price and Analyst Predictions - The News Heater
NAOV’s price-to-free cash flow ratio: A closer look at its relevance - US Post News
NanoVibronix Inc (NAOV) is looking forward to a strong quarter - SETE News
Pre-market Movers: SLGL, VIRX, ANVS, CUTR... - RTTNews
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
NanoVibronix Secures $12M Minimum Purchase Commitment for PainShield - MPO-mag
NanoVibronix Announces Exclusive Agreement for Distribution of PainShield(R) and UroShield(R) in Italy - ACCESS Newswire
NanoVibronix stock touches 52-week low at $0.44 amid market challenges - MSN
NanoVibronix stock touches 52-week low at $0.44 amid market challenges By Investing.com - Investing.com South Africa
NanoVibronix’s UroShield trial results hold potential to advance urinary care: GlobalData - Express Healthcare
NanoVibronix stock touches 52-week low at $0.46 amid market challenges - Investing.com Canada
Nanovibronix Inc Stock (NAOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.40%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):